At the recent SECO meeting, optometrists and ophthalmic technicians sat side by side learning to perform microblepharoexfoliation (MBE), a new therapy for the treatment of blepharitis and ocular surface disease. The program aimed to train both doctor and tech about blepharitis and how to use the BlephEx device.
Lid and Lash
The mainstay of our therapy today consists of artificial tear preparations, surfactant lid cleansers, warm compresses for the eyelids, and the occasional antibiotic solution or ointment—this is the exact same therapy that was in vogue for treating OSD 25 years ago!
RELIEF TO THE RESCUE
BlephEx recently released the first medical device that allows doctors to perform a painless, in-office procedure to treat blepharitis.
Everything from our high-tech lifestyles outdoor environmental factors, and the general aging of the population can lead to blepharitis, dry eye disease (DED) and meibomian gland dysfunction (MGD). Sustained tasks, such as reading, can reduce the blink rate to as low as five blinks per minute. This slow blink rate can cause additional stress on an ocular surface that is already compromised due to one of the aforementioned disorders.
Kelly Nichols, OD, FAAO, PhD, MPH, Dipl PH, says she would like to see optometrists screen for meibomian gland dysfunction during eye exams and consider the condition when treating patients who are experiencing discomfort with their contact lenses.